Patient-derived organoids were isolated and cultured using minor modifications of a protocol previously published by Lee et al. [14]. Tumour tissues from patients were washed in PBS containing penicillin/streptomycin. Tumour tissues were minced with scissors and incubated in 10 mL of the organoid culture medium (hepatocyte medium with 10 ng/mL EGF, 5% charcoal-stripped FBS, 10 mM Y-27632, 100 mg/mL Primocin, and 1× Glutamax) supplemented with 1 mL collagenase/hyaluronidase (STEMCELL Technologies) at 37 °C for 15 min. Dissociated tissues were spun down at 300 g for 5 min, resuspended in 10 mL of PBS, and spun down again. The tissues were resuspended in 5 mL of TrypLE Express (Invitrogen, Life Technologies, Carlsbad, CA, USA) and incubated at room temperature for 3 min. Dissociated tissues were spun down at 300 g for 5 min, resuspended in 10 mL of HBSS supplemented with 5% charcoal-stripped FBS, 10 mM Y-27632 and 100 mg/mL Primocin, and passed through a 100 μm cell strainer. Dissociated cells (1 × 106 cells/well) were spun down at 300 g for 5 min, resuspended in 60% Matrigel/organoid culture medium, plated in a 250 μL drop in the middle of one well of a pre-coated 6-well plate with 60% Matrigel, and solidified at 37 °C for 30 min. After solid drops formed, 1.5 mL of the organoid culture media was added to the well.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.